For free and confidential advice about alcohol and other drugs, call the National Alcohol and Other Drug hotline: 1800 250 015. It will automatically direct you to the Alcohol and Drug Information Service in your state or territory. Click here for more information
New evidence
based knowledge
NCCRED are producing a series of VANs showcasing NCCRED supported research, developed for both consumers and healthcare professionals.
Sign up to our email list to get new video abstracts when they’re published.
Published 4 November 2024
Methamphetamine use affects the person using the drug, but it can also affect their family and friends. This video abstract explains the evaluation of an online delivery of Smart Family & Friends, a structured mutual support group.
This video abstract is based on a paper published in the Journal of Substance Use and Addiction Treatment in June 2024.
Published 8 March 2024
In Australia, women have been shown to be as likely as men to use methamphetamine weekly. But women make up less than a third of people who access treatment for methamphetamine use disorder.
The paper, published in BMC Health Services Research, is based on interviews with 11 women recruited from an inner-city hospital in Sydney. Read the paper: https://nccred.org.au/wp-content/uploads/2023/03/s12913-023-09125-z.pdf
Published 23 October 2023
Wada Wanti is an evidence-based web app designed to help Aboriginal and Torres Strait Islander People to stop or reduce their use of methamphetamine. Jason Ramp interviewed clients and lived experience workers at the Healing Circle in Port Lincoln, South Australia to explore how Wada Wanti would fit in to the service and the lives of clients.
Published on 26 June 2023
This project analysed 10,000 deidentified electronic medical records from NSW, seeking to describe what people who use methamphetamine have in common. This includes identifying how frequently they use, the level and types of other substance use, their quality of life and whether they’re having problems like being arrested or experiencing violence.
Published on 24 April 2023
An NCCRED supported mini review finds that technologically assisted interventions for methamphetamine use were most useful for people not already linked with treatment; future research will also explore how technology can be best integrated with existing treatment.
Published on 12 April 2023
This VAN presents the results of a training needs analysis conducted with staff from Australian Alcohol and Other Drug telephone helplines. These helplines take over 100,000 calls annually.
In regard to Methamphetamine and Emerging Drugs of Concern; the results found a need for:
Published on 6 February 2023
The OLAM study investigates the safety and feasibility of lisdexamphetamine (a stimulant medication) to assist people in methamphetamine withdrawal.
The results of our study showed Lisdexamphetamine to be a safe and feasible pharmacotherapy for people experiencing methamphetamine withdrawal.
The results are promising but more research (a randomized control trial) is required.
Published on 11 July 2022
This VAN explores what we know about methamphetamine withdrawal, and how treating it might be approached.
Using the results of a systematic review and meta-analysis, we discuss what medications have been trialled to date, whether or not they worked, and the impact of these results in clinical practice.
Published on 29 March 2022
The GHB Cultures Practices and Experiences Study was conducted to inform GHB campaigns and services for sexuality and gender diverse communities.
Overall, most people in our study, reported that they enjoy using but emphasised that it is essential to be educated about G GHB and carefully practice harm reduction strategies to manage risk.
National Centre for Clinical
Research on Emerging Drugs
We would like to acknowledge the Traditional Owners of this country
and pay our respects to Elders past, present and emerging.